Abstract
purpose. To test whether variation in extracellular cysteine (Cys) redox potential (Eh) over the physiologic range occurring in human plasma affects oxidant-induced apoptosis in cultured human retinal pigment epithelial (hRPE) cells.
methods. The hRPE cells were incubated in culture medium with Eh established over the range of −16 mV (most oxidized) to −158 mV (most reduced) by adding different concentrations of Cys and cystine (CySS) with constant total Cys equivalents. Apoptosis was induced with tert-butylhydroperoxide (tBH).
results. The hRPE cells were sensitized to tBH-induced apoptosis in the more oxidized extracellular conditions (Eh > −55 mV) compared with the reduced conditions (Eh < −89 mV). Loss of mitochondrial membrane potential (Δψm), release of cytochrome c, and activation of caspase 3 after tBH treatments all increased under the more oxidized conditions. However, the extracellular redox state did not affect expression of Fas or FasL in hRPE cells.
conclusions. The hRPE cells that are exposed to a more oxidized extracellular redox environment have increased susceptibility to oxidant-induced apoptosis through the intrinsic mitochondrial pathway, which could contribute to an age-related decline in cell populations in the retina and thereby provide a potential mechanism for the degenerative changes that are associated with age-related macular degeneration (ARMD).
The redox regulatory mechanisms are distinct among various cellular and extracellular compartments. Each compartment contains different pools of thiol/disulfide couples, such as glutathione (GSH)/glutathione disulfide (GSSG), cysteine (Cys)/cystine (CySS), and dihydrolipoic acid/lipoic acid.
1 The functions of these redox couples are dependent on both the ratio and total concentrations of the reduced and oxidized forms, the inherent electron donating/accepting characters that are defined by the relative standard potential (E
0) values of the respective couples, and the kinetics of interactions of the components. GSH is the predominant cellular thiol and is maintained at millimolar concentrations with redox potentials ranging from −260 to −200 mV.
2 In human plasma, the GSH concentration is <4 μM, and the GSH/GSSG redox state is much more oxidized than the intracellular redox state—for example, about −140 mV. The plasma concentrations of CySS and Cys are 40 to 50 μM and 8 to 10 μM, respectively.
3 The redox potential of the plasma Cys/CySS pool is −80 ± 9 mV and is more oxidized than GSH/GSSG.
3 Decreased concentrations of plasma Cys and GSH have been implicated in a number of human diseases such as Alzheimer’s and Parkinson’s, diabetes, cystic fibrosis, and HIV infection.
4 5 6 7
Considerable evidence is available to show that thiols protect against oxidant-induced apoptosis, and this has often been linked to maintenance of cellular GSH pools.
8 9 GSH functions in elimination of peroxides and lipid peroxidation as well as direct reaction with free radicals.
10 11 12 Although protection against oxidative stress clearly can occur by detoxification of reactive oxygen intermediates, accumulating evidence indicates that low-molecular-weight thiols also have a fundamental role through effects on protein thiol/disulfide redox state.
11 13 Changes in the thiol/disulfide redox state alter signal transduction, DNA and RNA synthesis, protein synthesis, enzyme activation, and cell cycle regulation.
11 13 14
One common aging disease, age-related macular degeneration (ARMD), is the leading cause of blindness in elderly Americans.
15 One theory is that oxidative damage contributes to disease onset and progression.
16 This theory is supported by epidemiologic studies that have demonstrated that high serum carotenoid levels are associated with a decreased risk of neovascular ARMD
17 and that a combination of vitamin C, vitamin E, β-carotene, and zinc significantly reduced the risk of advanced ARMD and associated vision loss.
18 Specifically, vision loss in ARMD occurs through photoreceptor damage in the macula, with abnormalities in the retinal pigment epithelium (RPE) and Bruch’s membrane being the hallmark of the disease.
19 Studies have demonstrated that apoptotic cells are present in the RPE of eyes with ARMD, indicating that apoptosis in RPE cells could contribute to ARMD.
20 21 Because of its anatomic location, the RPE is primed for oxidant and free radical production and has an extraordinary need for antioxidant protection.
16 22 23 24 The GSH antioxidant system may play a large role in RPE protection, but the RPE has limited capacity to take up exogenous GSH.
25 Therefore, the maintenance of cellular GSH levels in RPE is largely dependent on GSH synthesis. The age-related decline of plasma Cys is associated with an oxidation of both the Cys/CySS and GSH/GSSG redox states in human plasma.
3 6 26 This decline may compromise the antioxidant function of RPE by limiting the GSH synthesis and render RPE cells susceptible to oxidative stress, which may serve as one mechanism of RPE injury in ARMD. Accordingly, there is a general consensus that oxidative damage to RPE contributes to the initiation and progression of ARMD.
22 23 24
Our previous in vitro studies have demonstrated that pro-oxidants can cause apoptosis through both the intrinsic (mitochondrial) and extrinsic (death receptor) pathways in cultured human RPE (hRPE) cells.
27 28 29 In the extrinsic pathway, FasL binds its receptor, Fas, which belongs to the tumor necrosis factor receptor superfamily. Binding to Fas triggers a signal transduction pathway, ultimately ending in apoptosis in cells that express Fas.
30 In addition, the mitochondria play a central role in regulation of the apoptotic pathway. An early event in this pathway is the mitochondrial permeability transition (MPT), which includes loss of mitochondrial membrane potential (Δψ
m). MPT activation results in release of cytochrome
c, which triggers caspase activation and apoptosis.
31 32 33 Both mechanisms work to ensure that apoptosis occurs in times of stress, and both may be important in degenerative changes associated with aging and age-related disease.
We recently found that the redox states of human plasma GSH and Cys pools become oxidized in association with increased age.
26 If such oxidation were to alter the sensitivity of cells to apoptosis, the thiol/disulfide redox state of plasma may be a central determinant of age-related degenerative processes. The present study tested the hypothesis that controlled variation in extracellular redox potential (E
h) over the physiological range would affect the sensitivity of hRPE cells to oxidant-induced apoptosis. The results show that hRPE cells were more susceptible to apoptosis under more oxidized redox potentials, which we established by varying the Cys and CySS concentrations. The intrinsic pathway for apoptosis, measured by loss of mitochondrial membrane potential, release of cytochrome
c, and activation of caspase 3, varied as a function of extracellular redox state; whereas no redox-dependent effects were observed for the death receptor Fas/FasL system. Thus, oxidant-induced apoptosis in hRPE cells signaled by the mitochondrial pathway is sensitive to the extracellular Cys/CySS redox state.
Apoptosis was induced by adding 300 μM tBH for the indicated time in DMEM medium with different ratios of Cys and CySS. DNA cleavage, which commonly occurs in apoptosis, was measured by terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) with a kit (In Situ Cell Death Detection Kit with Fluorescein; Roche Molecular Biochemicals, Mannheim, Germany) followed by flow cytometry. Phosphatidylserine exposure, another apoptotic feature, was determined with an annexin V-FITC kit (TACS; Trevigen, Gaithersburg, MD). Briefly, cells were resuspended in 100 μL of binding buffer containing 10 mM HEPES-KOH (pH 7.4), 150 mM NaCl, 5 mM KCl, 1 mM MgCl2, 1.8 mM CaCl2, 1 mg/mL annexin-V-FITC, and propidium iodide. After 15 minutes of incubation at room temperature in the dark, 400 μL of binding buffer was added, and cells were then analyzed by flow cytometry.
Expression of FasL and Fas on RPE cells was detected as described previously.
22 For flow cytometric detection of cell surface FasL, cells were sequentially stained with 2.5 μg/mL rabbit anti-FasL antibody (Santa Cruz Biotechnology Inc., Santa Cruz, CA) and 2.5 μg/mL FITC-conjugated anti-rabbit IgG (Pierce, Rockford, IL). For detection of cell surface Fas, cells were incubated with phycoerythrin (PE)-conjugated anti-Fas antibody (BD Biosciences-PharMingen). Cells stained with isotypically matched control IgG and FITC-conjugated secondary antibodies and cells stained with PE-conjugated isotypically matched control Ig were run in parallel as negative controls for FasL and Fas staining, respectively. The cells were then analyzed by flow cytometer.
Expression of total FasL and total Fas was determined by Western blot analysis. Cells were lysed in a boiling solution containing 10% glycerol, 250 mM Tris (pH 6.8), 4% SDS, and 2% β-mercaptoethanol. The cell lysates were boiled for 5 minutes and centrifuged at 10,000g for 5 minutes at 4°C. The supernatants (100 μg) were subjected to 12% SDS-polyacrylamide gel electrophoresis followed by transfer to PVDF membranes, and immunoblotted with antibodies against FasL and Fas (1:1000 dilution; Transduction Laboratories, Lexington, KY). FasL and Fas proteins were detected using horseradish peroxidase–labeled secondary antibody and enhanced chemiluminescence (NEN Life Science Products).
No Changes in Fas and FasL Expression in Cells Incubated in Different Extracellular Eh
Our present study of hRPE function in various extracellular redox conditions has shown that hRPE cells have the ability to modulate the extracellular redox pool. They were able to change the reduced and oxidized media to the redox state of −70 mV
(Fig. 1) , a value detected in normal human plasma. For those experiments, we used 80% to 90% confluent hRPE cells that were seeded onto 60-mm dishes with 4 mL of medium. The estimated cell volume was <5% of the medium volume. Although rapid oxidation of Cys to CySS may contribute to the change of extracellular redox to some extent, it could not explain the adjustment of extracellular redox to −70 mV in all media regardless of their initial redox status. When the media were placed alone (without hRPE cells) in the incubator for 24 hours, the E
h of the most oxidized medium (−16 mV) was −3 mV, whereas the E
h of the most reduced medium (−158 mV) became −24 mV. The media incubated alone had Cys concentrations around 1 μM, whereas the media cultured with hRPE cells had 5 to 10 times higher concentrations of Cys. Moreover, compared with the media incubated alone, the media cultured with hRPE cells had relatively lower CySS concentrations. Thus, the observed redox changes
(Fig. 1)were not solely caused by air oxidation of Cys in the media. The results indicate that an important characteristic of hRPE cells is that they regulate the thiol/disulfide redox state in their extracellular environment.
In spite of this ultimate stabilization of extracellular redox, the data show that a more oxidized extracellular Cys/CySS sensitized hRPE to oxidant-induced apoptosis. We previously found that both GSH and Cys protect hRPE cells from tBH-induced cell death but the mechanisms involved are different.
25 Although Cys can protect cells from oxidative injury by elevating intracellular GSH, GSH is not transported into the cells and may act on the cell membrane of hRPE. The present research and previous studies have shown that variation in extracellular Cys/CySS results in little change in cellular GSH and GSSG concentrations.
36 The measured GSSG levels had nearly 20% variations between experimental replicates, due to limitations of the analytical procedures. However, the results (
Fig. 2and Ref.
36 ) consistently supported the interpretation that extracellular Cys/CySS redox was not linked to intracellular GSH/GSSG redox. Therefore, this suggests a regulatory mechanism specifically controlled by extracellular Cys/CySS redox and also implies that the extracellular redox sensitivity involves other signal transduction systems in addition to the expected thiol-dependent antioxidant effects.
Exogenously added GSH or
N-acetyl cysteine (NAC) can effectively downregulate cell surface Fas and FasL expression in hRPE cells and therefore inhibit Fas-mediated apoptosis.
27 However, the present studies show that change in extracellular Cys/CySS redox does not affect Fas or FasL expression. Instead, the data show that the altered sensitivity to apoptosis is mediated by the mitochondrial pathway, as evidenced by mitochondrial membrane potential loss, cytochrome
c release, and caspase 3 activation. Because this occurs without detectable change in cellular GSH/GSSG redox, the data indicate that the response may be mediated by cell signaling components in the plasma membrane. Such an interpretation is consistent with recent models of cell survival pathways, such as those involving insulin-like growth factor receptor (IGFR), AKT, and forkhead transcription factors, which serve to orchestrate cell survival and apoptosis signaling.
37 38
Accumulating evidence indicates that oxidation of the extracellular thiol/disulfide redox state not only provides a biomarker of oxidative stress,
8 9 11 12 but also contributes to disease development by inhibiting cell proliferation
8 and decreasing resistance to infection.
4 5 39 Cys concentration in plasma declines with age and, along with an increase of CySS, results in an oxidation of the redox value for Cys/CySS.
3 6 34 When controlled for age, conditions of oxidative stress, such as cigarette smoking
40 and high-dose chemotherapy
41 result in oxidation of plasma Cys/CySS and GSH/GSSG redox states. Oxidation of the plasma thiol/disulfide redox state has also been associated with type 2 diabetes
6 and cardiovascular disease.
42 Results from the present study suggest that a common consequence of the plasma redox changes is to sensitize affected cells to mitochondria-mediated apoptosis.
In addition to clinical studies, in vitro oxidation of extracellular redox state occurs in association with growth arrest, cellular differentiation, and apoptosis.
36 28 43 44 The present study shows that oxidized thiol/disulfide redox state enhances the sensitivity of RPE cells to oxidant-induced apoptosis. In our experiments, we have used a standard model of oxidative stress to postmortem cultured hRPE cells that has been replicated by other laboratories. We recognize that these cells are capable of active division and that this may affect their susceptibility to injury. Data from other laboratories indicate that differentiation status of the cultured cells may influence the cellular response to oxidative stress.
45 In fact, we have developed an alternative model in which we age the hRPE cells in vitro and are able to render them postmitotic.
28 In this setting, which is likely to mimic the in vivo scenario more closely, the hRPE cells demonstrate even greater sensitivity to oxidative injury than in the model chosen for this project. Those cells also showed more oxidized intracellular GSH redox. Thus, both intracellular and extracellular redox status contribute to the sensitivity of RPE to oxidative stress. Although we used only the chemical oxidant tBH for most of the studies, a similar redox regulatory mechanisms may also be applied to other acute toxicities, such as light-induced damage to the retina.
In conclusion, this study shows that hRPE cells can regulate their extracellular redox state, but that oxidation of the extracellular thiol/disulfide redox state increases hRPE cell susceptibility to oxidative injury. This indicates that a shift in the extracellular redox state in vivo could play an important role in RPE cell function and contribute to apoptosis of RPE cells undergoing oxidative stress. Because of this, the extracellular thiol/disulfide redox state may represent a physiologic environment in which other oxidative challenges, such as infection, activation of the immune system, or other stress conditions, result in enhanced RPE cell loss and development of ARMD. Consequently, manipulation of the plasma thiol/disulfide redox state to a more reduced level may decrease the sensitivity of the retina and RPE to apoptosis from oxidative stress.
Supported by National Eye Institute Grants EY07892, EY06360, EY08126, and ES09047; grants from American Federation for Aging Research, Research to Prevent Blindness, Inc., the Wasserman Award from Research to Prevent Blindness; and the Foundation Fighting Blindness.
Submitted for publication August 5, 2004; revised October 13, 2004; accepted November 20, 2004.
Disclosure:
S. Jiang, None;
S.E. Moriarty-Craige, None;
M. Orr, None;
J. Cai, None;
P. Sternberg,
Jr, None;
D.P. Jones, None
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be marked “
advertisement” in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Corresponding author: Paul Sternberg, Jr, Vanderbilt Eye Institute, 8030 Medical Center East, Nashville, TN 37232-8808;
[email protected].
Table 1. Preparation of DMEM with Different CyS/CySS Redox Potential
Table 1. Preparation of DMEM with Different CyS/CySS Redox Potential
CyS (μM) | CySS (μM) | Eh (mV) |
200 | 0 | −158 |
80 | 60 | −119 |
40 | 80 | −89 |
14 | 93 | −55 |
4 | 98 | −30 |
0 | 100 | −16 |
DenekeSM. Thiol-based antioxidants. Curr Top Cell Regul. 2000;36:151–180.
[PubMed]KirlinWG, CaiJ, ThompsonSA, et al. Glutathione redox potential in response to differentiation and enzyme inducers. Free Radic Biol Med. 1999;27:1208–1218.
[CrossRef] [PubMed]JonesDP, CarlsonJL, ModyVC, et al. Redox state of glutathione in human plasma. Free Radic Biol Med. 2000;28:625–635.
[CrossRef] [PubMed]BuhlR, JaffeHA, HolroydKJ, et al. Systemic glutathione deficiency in symptom-free HIV-seropositive individuals. Lancet. 1989;2:1294–1298.
[PubMed]RoumJH, BuhlR, McElvaneyNG, et al. Systemic deficiency of glutathione in cystic fibrosis. J Appl Physiol. 1993;75:2419–2424.
[PubMed]SamiecPS, Drews-BotschC, FlaggEW, et al. Glutathione in human plasma: decline in association with aging, age-related macular degeneration, and diabetes. Free Radic Biol Med. 1998;24:699–704.
[CrossRef] [PubMed]BainsJS, ShawCA. Neurodegenerative disorders in humans: the role of glutathione in oxidative stress-mediated neuronal death. Brain Res Brain Res Rev. 1997;25:335–358.
[CrossRef] [PubMed]MatesJM, Perez-GomezC, Nunez de CastroI, et al. Glutamine and its relationship with intracellular redox status, oxidative stress and cell proliferation/death. Int J Biochem Cell Biol. 2002;34:439–458.
[CrossRef] [PubMed]HallAG. Review: the role of glutathione in the regulation of apoptosis. Eur J Clin Invest. 1999;29:238–245.
[CrossRef] [PubMed]Di MascioP, MurphyME, SiesH. Antioxidant defense systems: the role of carotenoids, tocopherols, and thiols. Am J Clin Nutr. 1991;53:194S–200S.
[PubMed]SenCK. Cellular thiols and redox-regulated signal transduction. Curr Top Cell Regul. 2000;36:1–30.
[PubMed]SchaferFQ, BuettnerGR. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic Biol Med. 2001;30:1191–1212.
[CrossRef] [PubMed]MoranLK, GutteridgeJM, QuinlanGJ. Thiols in cellular redox signalling and control. Curr Med Chem. 2001;8:763–772.
[CrossRef] [PubMed]KamataH, HirataH. Redox regulation of cellular signalling. Cell Signal. 1999;11:1–14.
[CrossRef] [PubMed]KleinBE, KleinR. Cataracts and macular degeneration in older Americans. Arch Ophthalmol. 1982;100:571–573.
[CrossRef] [PubMed]BeattyS, KohH, PhilM, et al. The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Ophthalmol. 2000;45:115–134.
[CrossRef] [PubMed]Risk factors for neovascular age-related macular degeneration. The Eye Disease Case-Control Study Group. Arch Ophthalmol. 1992;110:1701–1708.
[CrossRef] [PubMed]Age-Related Eye Disease study group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss: AREDS report no. 9. Arch Ophthalmol. 2001;119:1439–1452.
[CrossRef] [PubMed]YoungRW. Pathophysiology of age-related macular degeneration. Surv Ophthalmol. 1987;31:291–306.
[CrossRef] [PubMed]IshibashiT, SorgenteN, PattersonR, et al. Pathogenesis of drusen in the primate. Invest Ophthalmol Vis Sci. 1986;27:184–193.
[PubMed]DunaiefJL, DentchevT, YingGS, et al. The role of apoptosis in age-related macular degeneration. Arch Ophthalmol. 2002;120:1435–1442.
[CrossRef] [PubMed]CaiJ, NelsonKC, WuM, et al. Oxidative damage and protection of the RPE. Prog Retin Eye Res. 2000;19:205–221.
[CrossRef] [PubMed]AlderVA, CringleSJ. The effect of the retinal circulation on vitreal oxygen tension. Curr Eye Res. 1985;4:121–129.
[CrossRef] [PubMed]RozanowskaM, Jarvis-EvansJ, KorytowskiW, et al. Blue light-induced reactivity of retinal age pigment: in vitro generation of oxygen-reactive species. J Biol Chem. 1995;270:18825–18830.
[CrossRef] [PubMed]SternbergP, Jr, DavidsonPC, JonesDP, et al. Protection of retinal pigment epithelium from oxidative injury by glutathione and precursors. Invest Ophthalmol Vis Sci. 1993;34:3661–3668.
[PubMed]JonesDP, ModyVC, Jr, CarlsonJL, et al. Redox analysis of human plasma allows separation of pro-oxidant events of aging from decline in antioxidant defenses. Free Radic Biol Med. 2002;33:1290–1300.
[CrossRef] [PubMed]JiangS, WuMW, SternbergP, et al. Fas mediates apoptosis and oxidant-induced cell death in cultured hRPE cells. Invest Ophthalmol Vis Sci. 2000;41:645–655.
[PubMed]JiangS, MoriartySE, GrossniklausH, et al. Increased oxidant-induced apoptosis in cultured nondividing human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci. 2002;43:2546–2553.
[PubMed]CaiJ, WuM, NelsonKC, et al. Oxidant-induced apoptosis in cultured human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci. 1999;40:959–966.
[PubMed]ChinnaiyanAM, DixitVM. Portrait of an executioner: the molecular mechanism of FAS/APO-1-induced apoptosis. Semin Immunol. 1997;9:69–76.
[CrossRef] [PubMed]ZorattiM, SzaboI. The mitochondrial permeability transition. Biochim Biophys Acta. 1995;1241:139–176.
[CrossRef] [PubMed]KantrowSP, PiantadosiCA. Release of cytochrome c from liver mitochondria during permeability transition. Biochem Biophys Res Commun. 1997;232:669–671.
[CrossRef] [PubMed]GreenDR, ReedJC. Mitochondria and apoptosis. Science. 1998;281:1309–1312.
[CrossRef] [PubMed]SamaliA, CaiJ, ZhivotovskyB, JonesDP, OrreniusS. Presence of a pre-apoptotic complex of pro-caspase-3, Hsp 60 and Hsp 10 in the mitochondrial fraction of Jurkat cells. EMBO J. 1999;18:2040–2048.
[CrossRef] [PubMed]CaiJ, JonesDP. Superoxide in apoptosis: mitochondrial generation triggered by cytochrome c loss. J Biol Chem. 1998;273:11401–11404.
[CrossRef] [PubMed]JonasCR, ZieglerTR, GuLH, et al. Extracellular thiol/disulfide redox state affects proliferation rate in a human colon carcinoma (Caco2) cell line. Free Radic Biol Med. 2002;33:1499–1506.
[CrossRef] [PubMed]BirkenkampKU, CofferPJ. Regulation of cell survival and proliferation by the FOXO (Forkhead box, class O) subfamily of Forkhead transcription factors. Biochem Soc Trans. 2003;31:292–297.
[PubMed]BurgeringBM, MedemaRH. Decisions on life and death: FOXO Forkhead transcription factors are in command when PKB/Akt is off duty. J Leukoc Biol. 2003;73:689–701.
[CrossRef] [PubMed]NaisbittDJ, VilarFJ, StalfordAC, et al. Plasma cysteine deficiency and decreased reduction of nitrososulfamethoxazole with HIV infection. AIDS Res Hum Retroviruses. 2000;16:1929–1938.
[CrossRef] [PubMed]MoriartySE, ShahJH, LynnM, et al. Oxidation of glutathione and cysteine in human plasma associated with smoking. Free Radic Biol Med. 2003;35:1582–1588.
[CrossRef] [PubMed]JonasCR, PuckettAB, JonesDP, et al. Plasma antioxidant status after high-dose chemotherapy: a randomized trial of parenteral nutrition in bone marrow transplantation patients. Am J Clin Nutr. 2000;72:181–189.
[PubMed]AnderssonA, HutlbergB, LindgrenA. Redox status of plasma homocysteine and other plasma thiols in stroke patients. Atherosclerosis. 2000;151:535–539.
[CrossRef] [PubMed]NkabyoYS, ZieglerTR, GuLH, et al. Glutathione and thioredoxin redox during differentiation in human colon epithelial (Caco-2) cells. Am J Physiol. 2002;283:G1352–G1359.
WatsonWH, ChenY, JonesDP. Redox state of glutathione and thioredoxin in differentiation and apoptosis. Biofactors. 2003;17:307–314.
[CrossRef] [PubMed]HondaJT, FarboundB, HjelmelandLM, HandaJT. Induction of an aging mRNA retinal pigment epithelial cell phenotype by matrix-containing advanced glycation end products in vitro. Invest Ophthalmol Vis Sci. 2001;42:2419–2425.
[PubMed]